Try our new website and tell us what you think. Take me there|

Domino invited to present Falsified Medicines Directive expertise at RACI 2013 conference

30th April 2013: Domino Printing Sciences, world leader in coding and marking solutions, will be speaking at the 31st RACI (Annual Meeting of the College of Pharmaceutical Industry) conference, which sees top executives from all aspects of the Portuguese pharmaceutical industry come together to share knowledge on current trends.

Organised by pharmaceutical representative body Ordem Farmaceuticos, Domino has been invited to share its expertise on the European Union’s Falsified Medicines Directive (FMD), in order to aid the conference’s intention of ‘addressing some of the most pressing issues for the pharmaceutical industry’.

Bart Vansteenkiste, European Union life sciences sector manager at Domino, will speak on the morning of the 25th May, when he will highlight the challenges pharmaceutical manufacturers will face when the FMD comes in to force in 2016. The FMD is aimed at reducing the numbers of falsified medicines infiltrating the legal pharmaceutical supply chain within the European Economic Area, and Vansteenkiste will advise manufacturers on the best solutions to becoming compliant whilst also maintaining operating efficiencies and profit margins.

“RACI brings together 150 of the most knowledgeable pharmaceutical executives in Portugal, and it is a privilege to be one of just 12 speakers presenting to such an impressive audience,” says Vansteenkiste. “Domino has been working closely with our customers to provide advice and act as partners in change since the Directive was published, and it’s clear that the road to compliance will undoubtedly be challenging for many parts of the industry. We have provided counsel to various manufacturers and I am honoured to be sharing our learnings and advice at this year’s RACI conference.”

Posted on Monday 18th November 2013